ID
45777
Beskrivning
Principal Investigator: Susan K. Dutcher, McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001106 Despite the growing incidence of hepatocellular carcinoma (HCC) due to increased hepatitis C virus infection and non-alcoholic steatohepatitis in Western populations, the genetic determinants of this cancer have yet to be established. A minority (15-20%) of HCC occurs in livers without cirrhosis or other chronic disease. Because the liver is functionally preserved in these patients and surgical resection of the tumor may be performed safely, and because of the scarcity of livers available for transplantation, non-cirrhotic patients undergo surgical resection for HCC treatment. These resected tumors present investigatory opportunities in two ways: First, they provide tumor specimen which have not been treated with chemotherapy and embolization. Second, the absence of cirrhosis may provide an unconfounded background from which to investigate the genetic tumorigenesis of HCC. In livers with cirrhosis, genetic instability is prevalent as assessed by assays for microsatellite instability, loss of heterozygosity and aberrant DNA methylation. In contrast, in livers without cirrhosis, the non-tumor tissue surrounding HCC have been found to have fewer genetic aberrations. It has been postulated that the pathologic process of cirrhosis may result in the accumulation of many "passenger"; as well as "driver" mutations, and that the examination of the HCC cancer genome may be facilitated in non-cirrhotic livers because of the absence of an accumulated background noise of mutations.
Länk
Nyckelord
Versioner (1)
- 2023-06-20 2023-06-20 - Chiara Middel
Rättsinnehavare
Susan K. Dutcher, McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA
Uppladdad den
20 juni 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001106 Genomics of Hepatocellular Carcinoma
Subject ID, affection status, and consent group of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- Subject ID and sample ID of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, and in-house sample identifier of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- Subject ID, gender, race, sequencing group, admission or recurrence, alpha-fetoprotein, BMI, diabetes mellitus, follow-up, hypertension, liver disease, tumor characteristics, and treatment of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
Similar models
Subject ID, affection status, and consent group of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- Subject ID and sample ID of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, and in-house sample identifier of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
- Subject ID, gender, race, sequencing group, admission or recurrence, alpha-fetoprotein, BMI, diabetes mellitus, follow-up, hypertension, liver disease, tumor characteristics, and treatment of participants with hepatocellular carcinoma and involved in the "Genomics of Hepatocellular Carcinoma" project.
C2348585 (UMLS CUI [1,2])
C2697585 (UMLS CUI [1,2])
C0871641 (UMLS CUI [1,3])
C0449438 (UMLS CUI [1,4])